Skip to main content
Loading ResearchHub…
Cited by — Continuous Vutrisiran Reduces Cardiovascular Events and Hospitalizations in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B One-Year Open Label Extension | ResearchHub - ResearchHub